Skip to main content
Atrás
Watch Compare

Aligos Therapeutics, Inc.

Calidad de datos: 100%
ALGS
NASDAQ Manufacturing Chemicals
$8.00
▲ $0.03 (0.31%)
Cap. Mercado: 49.32 M
Precio
$7.97
Cap. Mercado
49.32 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -82.50 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)-39.46%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-27.86%
Above sector avg (-54.44%)
ROIC-68.75%
Net Margin-1106.72%
Op. Margin-4024.93%

Seguridad

Debt / Equity
N/A
Current Ratio4.70
Interest Coverage-39.99

Valoración

PE (TTM|NTM)
-2.04 | -1.50
Below sector avg (-1.49)
P/B Ratio0.69
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1385 pares)
Métrica Acción Mediana del Sector
P/E -2.0 -1.5
P/B 0.7 1.6
ROE % -27.9 -54.4
Net Margin % -1106.7 -41.5
Rev Growth 5Y % — 1.9
D/E — 0.3

Precio Objetivo de Analistas

5 analistas
Buy
Actual
$8.00
+723.0%
Objetivo
$65.80
$20.00
$48.00
$175.00
Pronóstico
P/E Futuro -1.50
EPS Futuro -$5.34
Ingresos Est. 2.23 M

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$5.34
-$7.58 – -$3.85
 2.23 M 3
FY2026 -$6.53
-$8.25 – -$4.68
 2.13 M 4

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$2.49 -$1.91 +23.2%
Q32025 -$2.01 -$3.04 -51.2%
Q22025 -$2.54 -$1.53 +39.6%
Q12025 -$3.15 $5.12 +262.4%

ETFs Holding This Stock

AVSCX AVSCX
0.00% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -39.46% Revenue Growth (3Y) -40.58%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.19 M Net Income (TTM) -24.19 M
ROE -27.86% ROA -19.79%
Gross Margin N/A Operating Margin -4024.93%
Net Margin -1106.72% Free Cash Flow (TTM) -82.50 M
ROIC -68.75% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.70
Interest Coverage -39.99 Asset Turnover 0.02
Working Capital 81.45 M Tangible Book Value 71.83 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.04 Forward P/E -1.50
P/B Ratio 0.69 P/S Ratio 22.56
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 22.16 Fwd Earnings Yield N/A
FCF Yield -167.29%
Market Cap 49.32 M Enterprise Value 7.37 M
Per Share
EPS (Diluted TTM) -2.45 Revenue / Share 0.35
FCF / Share -13.33 OCF / Share -13.33
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 341.02%
SBC-Adj. FCF -88.13 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.19 M 3.61 M 6.19 M 0.0 0.0
Net Income -24.19 M -131.21 M -87.68 M -96.05 M -128.33 M
EPS (Diluted) -2.45 -20.94 -1.36 — —
Gross Profit — — — — —
Operating Income -87.99 M -89.15 M -88.13 M -97.58 M -128.32 M
EBITDA — — — — —
R&D Expenses 69.45 M 70.27 M 73.04 M 85.08 M 104.15 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 2.20 M 1.70 M 4.30 M — —
Income Tax 314,000.0 331,000.0 795,000.0 106,000.0 143,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 88.53 M 70.09 M 151.53 M 146.69 M 235.37 M
Total Liabilities 34.99 M 99.07 M 59.45 M 42.79 M 50.64 M
Shareholders' Equity 53.55 M -28.97 M 92.08 M 103.90 M 184.73 M
Total Debt — — — — —
Cash & Equivalents 18.30 M 37.00 M 135.70 M 81.35 M 186.82 M
Current Assets 82.86 M 62.14 M 141.08 M 133.55 M 204.42 M
Current Liabilities 21.23 M 21.74 M 23.91 M 33.13 M 38.96 M